Myeloperoxidase to Risk Stratify Emergency Department Patients with Chest Pain

Previous studies suggest that serum myeloperoxidase (MPO) is a potentially useful biomarker to risk stratify troponin-negative patients with suspected myocardial ischemia. We hypothesized that the relationship between initial serum MPO levels would correlate with 30-day adverse cardiac outcomes for...

Descripción completa

Detalles Bibliográficos
Autores principales: Manini, Alex F., McAfee, Andrew T., Noble, Vicki E., Bohan, J. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Master Publishing Group 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614767/
https://www.ncbi.nlm.nih.gov/pubmed/23675127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614767/
https://www.ncbi.nlm.nih.gov/pubmed/23675127

Ejemplares similares